cytokeratin
- noun
- /ˌsaɪtoʊˈkɛrətɪn/
- Specialized
- The epithelial component exhibited a positive immunohistochemical reaction to cytokeratin and a negative reaction to vimentin, whereas the mesenchymal component showed a positive immunohistochemical reaction to vimentin and a negative reaction to cytokeratin.
- negative for cytokeratin
- positive for cytokeratin
- immunohistochemistry shows cytokeratin
Examples
-
The tumor cells were focally positive for synaptophysin and chromogranin but were negative for cytokeratin 7 and cytokeratin 5/6.
Academic text (2007) -
Interestingly, MCC has both neuroendocrine features, such as neurofilaments and neuroendocrine granules, and epithelial features, such as cytokeratin in their cytoplasm.
Academic text (2007) -
Immunohistochemistry was positive for cytokeratin and S-100 protein.
Academic text (2008) -
Histochemical staining for cytokeratin was negative, but strongly positive for thyroglobulin.
Academic text (1998) -
The tumor was immunonegative for S-100 protein, cytokeratin, and desmin.
Academic text (2006) -
Immunohistochemical studies show a positive reaction with vimentin, but negative for desmin, S-100 protein, and cytokeratin.
Academic text (1996) -
The reactions to epithelial membrane antigen (EMA) and cytokeratin were negative.
Academic text (2006) -
Immunostains demonstrated that the tumor cells were positive for cytokeratin 20 with a characteristic paranuclear dot-like pattern (Figure 4).
Academic text (2007) -
Immunohistochemical stains were positive for carcinoembryonic antigen (CEA) and low molecular weight cytokeratin.
Academic text (2007) -
In laboratory tests, the pathologist looked for the presence of cytokeratin in the tissue samples to help identify the tumor type.
Surface Forms
Morphology
Etymology
Cytokeratin comes from the parts cyto- 'cell' and keratin, the protein in hair and nails whose root means 'horn'. So cytokeratin is a 'horn-like' protein made in cells that helps give them structure and is often used in lab tests to identify cell types or tumors.